Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.70 |
| ▸ | CETP | P11597 | 3/20 | 0.53 |
| ▸ | SRC | P12931 | 1/20 | 0.49 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.49 |
| ▸ | MTOR | P42345 | 1/20 | 0.49 |
| ▸ | ALPG | P10696 | 1/20 | 0.49 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | IDO1 | P14902 | 1/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.46 |
| ▸ | LAP3 | P28838 | 3/20 | 0.46 |
| ▸ | ANPEP | P15144 | 1/20 | 0.46 |
| ▸ | AGXT | P21549 | 1/20 | 0.45 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL15169626 | 0.98 | TSHR (0.68) | TSHRCETPSRCPDPK1MTOR | |
| SCHEMBL6685550 | 0.83 | TSHR (0.76) | TSHRCETPSRCPDPK1MTOR | |
| SCHEMBL112789 | 0.83 | TSHR (0.63) | TSHRCETPSRCPDPK1MTOR | |
| SCHEMBL206610 | 0.83 | TSHR (0.76) | TSHRCETPSRCPDPK1MTOR | |
| SCHEMBL10931929 | 0.83 | TSHR (0.63) | TSHRCETPSRCPDPK1MTOR | |
| SCHEMBL51316 | 0.83 | TSHR (1.00) | TSHRCETPSRCPDPK1MTOR | |
| SCHEMBL27908642 | 0.83 | TSHR (1.00) | TSHRCETPSRCPDPK1MTOR | |
| SCHEMBL4219700 | 0.81 | TSHR (0.96) | TSHRCETPSRCPDPK1MTOR | |
| SCHEMBL9446520 | 0.81 | TSHR (0.96) | TSHRCETPSRCPDPK1MTOR | |
| Hydrochloric Acid SCHEMBL10722992 | 0.81 | TSHR (0.96) | TSHRCETPSRCPDPK1MTOR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230313074-A1 | WASHING AND CLEANING AGENTS HAVING IMPROVED ENZYME STABILITY | HENKEL AG & CO. KGAA (DE) | 2023-10-05 | — | — | US | claimed |
| EP-4200309-A1 | STEREOSELECTIVE MANUFACTURE OF SELECTED PURINE PHOSPHORAMIDATES | ATEA Pharmaceuticals, Inc. (US) | 2023-06-28 | — | — | EP | claimed |
| CN-115884977-A | Stereoselective preparation of selected purine phosphoramidates | 阿堤亚制药公司 | 2023-03-31 | — | — | CN | claimed |
| WO-2022040473-A1 | STEREOSELECTIVE MANUFACTURE OF SELECTED PURINE PHOSPHORAMIDATES | Atea Pharmaceuticals, Inc. (US) | 2022-02-24 | — | — | WO | claimed |
| WO-2021013684-A1 | DETERGENTS AND CLEANING AGENTS HAVING IMPROVED ENZYME STABILITY | HENKEL AG & CO. KGAA (DE) | 2021-01-28 | — | — | WO | claimed |
| CN-106188139-B | Tenofovir monobenzyl phosphoric acid amide prodrug, preparation method and application thereof | 江苏天士力帝益药业有限公司 | 2020-02-18 | — | — | CN | claimed |
| EP-0929636-B1 | LIQUID DETERGENTS CONTAINING PROTEOLYTIC ENZYME, PEPTIDE ALDEHYDE AND A SOURCE OF BORIC ACID | PROCTER & GAMBLE (US) | 2002-12-04 | — | — | EP | claimed |
| EP-0929639-B1 | LIQUID DETERGENTS CONTAINING PROTEOLYTIC ENZYME, PEPTIDE ALDEHYDE AND CALCIUM IONS | PROCTER & GAMBLE (US) | 2002-11-13 | — | — | EP | claimed |
| EP-0929636-A1 | LIQUID DETERGENTS CONTAINING PROTEOLYTIC ENZYME, PEPTIDE ALDEHYDE AND A SOURCE OF BORIC ACID | THE PROCTER & GAMBLE COMPANY (US) | 1999-07-21 | — | — | EP | claimed |
| EP-0929639-A1 | LIQUID DETERGENTS CONTAINING PROTEOLYTIC ENZYME, PEPTIDE ALDEHYDE AND CALCIUM IONS | THE PROCTER & GAMBLE COMPANY (US) | 1999-07-21 | — | — | EP | claimed |
| WO-1998013459-A1 | LIQUID DETERGENTS CONTAINING PROTEOLYTIC ENZYME, PEPTIDE ALDEHYDE AND CALCIUM IONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-04-02 | — | — | WO | claimed |
| WO-1998013462-A1 | LIQUID DETERGENTS CONTAINING PROTEOLYTIC ENZYME, PEPTIDE ALDEHYDE AND A SOURCE OF BORIC ACID | THE PROCTER & GAMBLE COMPANY (US) | 1998-04-02 | — | — | WO | claimed |
| US-20230331751-A1 | STEREOSELECTIVE MANUFACTURE OF SELECTED PURINE PHOSPHORAMIDATES | Atea Pharmaceuticals, Inc. (US) | 2023-10-19 | — | — | US | disclosed |
| US-20230313074-A1 | WASHING AND CLEANING AGENTS HAVING IMPROVED ENZYME STABILITY | HENKEL AG & CO. KGAA (DE) | 2023-10-05 | — | — | US | disclosed |
| WO-2022178428-A9 | TARGETED BIFUNCTIONAL DEGRADERS AND METHODS USING SAME | YALE UNIVERSITY (US) | 2023-08-17 | — | — | WO | disclosed |
| EP-4200309-A1 | STEREOSELECTIVE MANUFACTURE OF SELECTED PURINE PHOSPHORAMIDATES | ATEA Pharmaceuticals, Inc. (US) | 2023-06-28 | — | — | EP | disclosed |
| WO-1998013460-A1 | LIQUID DETERGENTS CONTAINING PROTEOLYTIC ENZYME AND PROTEASE INHIBITORS | THE PROCTER & GAMBLE COMPANY (US) | 1998-04-02 | — | — | WO | disclosed |
| WO-1998013461-A1 | LIQUID LAUNDRY DETERGENT COMPOSITIONS CONTAINING PROTEOLYTIC ENZYME AND PROTEASE INHIBITORS | THE PROCTER & GAMBLE COMPANY (US) | 1998-04-02 | — | — | WO | disclosed |
| WO-1998013462-A1 | LIQUID DETERGENTS CONTAINING PROTEOLYTIC ENZYME, PEPTIDE ALDEHYDE AND A SOURCE OF BORIC ACID | THE PROCTER & GAMBLE COMPANY (US) | 1998-04-02 | — | — | WO | disclosed |
| WO-1998013458-A1 | LIQUID DETERGENTS CONTAINING PROTEOLYTIC ENZYME AND PROTEASE INHIBITORS | THE PROCTER & GAMBLE COMPANY (US) | 1998-04-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230331751-A1 | STEREOSELECTIVE MANUFACTURE OF SELECTED PURINE PHOSPHORAMIDATES | NUDT1, PNP, ATIC | TSHR 3475/4885CETP 4214/4885SRC 3618/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.